World Journal of Surgery

, Volume 34, Issue 6, pp 1343–1349 | Cite as

Secondary and Tertiary Hyperparathyroidism: The Utility of ioPTH Monitoring

  • Susan C. Pitt
  • Rajarajan Panneerselvan
  • Herbert Chen
  • Rebecca S. Sippel



The aim of the present study was to examine the utility of intraoperative parathyroid hormone (ioPTH) monitoring in patients with secondary (2) and tertiary (3) hyperparathyroidism (HPT).

Materials and methods

We identified 105 patients with 2HPT (n = 33) and 3HPT (n = 72) who underwent ioPTH monitoring during parathyroidectomy. Data are reported as mean ± SEM.


The 2HPT patients underwent 17 subtotal, 10 total, and 6 re-exploratory parathyroidectomies, whereas the 3HPT patients underwent 54 subtotal, 15 limited, and 3 re-exploratory parathyroidectomies. The percent decrease from the baseline ioPTH level at 5, 10, and 15 min after parathyroid resection, respectively, were 72% ± 3%, 76% ± 3%, and 76% ± 3% in patients with 2HPT, and 52% ± 6%, 60% ± 4%, and 69% ± 4% in patients with 3HPT. IoPTH levels failed to drop >50% from baseline in 5 patients (2HPT: n = 2, 3HPT: n = 3) who were normocalcemic at last follow-up. IoPTH did not alter the surgical approach in any 2HPT patients, but did alter management in 25% of 3HPT patients (15 limited resections and 3 supernumerary glands). Normocalcemia was achieved in 97% of 2HPT patients and 99% of 3HPT patients; 2 patients developed recurrent disease.


Intraoperative PTH levels fell by >50% in nearly 95% of patients with 2HPT and 3HPT, and the PTH level reliably predicted postoperative cure. Although the use of ioPTH did not alter surgical management in any patient with 2HPT, this rapid PTH assay affected the surgical care of a quarter of the patients with 3HPT, and it may prove to be a useful adjunct in this group of patients.


  1. 1.
    Triponez F, Clark O, Vanrenthergem Y et al (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248:18–30CrossRefPubMedGoogle Scholar
  2. 2.
    Memmos D, Williams G, Eastwood J et al (1982) The role of parathyroidectomy in the management of hyperparathyroidism in patients on maintenance haemodialysis and after renal transplantation. Nephron 30:143–148CrossRefPubMedGoogle Scholar
  3. 3.
    Haustein S, Mack E, Starling J et al (2005) The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 138:1066–1071 (discussion 1071)CrossRefPubMedGoogle Scholar
  4. 4.
    Kebebew E, Duh Q, Clark O (2004) Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy. Arch Surg 139:974–977CrossRefPubMedGoogle Scholar
  5. 5.
    Kerby J, Rue L, Blair H et al (1998) Operative treatment of tertiary hyperparathyroidism: a single-center experience. Ann Surg 227:878–886CrossRefPubMedGoogle Scholar
  6. 6.
    Pasieka J, Parsons L (2000) A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 128:531–539CrossRefPubMedGoogle Scholar
  7. 7.
    Chen H (2002) Surgery for primary hyperparathyroidism: what is the best approach? Ann Surg 236:552–553CrossRefPubMedGoogle Scholar
  8. 8.
    Chen H, Mack E, Starling J (2003) Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238:332–337 (discussion 337–338)CrossRefPubMedGoogle Scholar
  9. 9.
    Chen H, Mack E, Starling J (2005) A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable? Ann Surg 242:375–380 (discussion 380–373)PubMedGoogle Scholar
  10. 10.
    Ito F, Sippel R, Lederman J et al (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963CrossRefPubMedGoogle Scholar
  11. 11.
    Dackiw AP, Sussman JJ, Fritsche HA Jr et al (2000) Relative contributions of technetium Tc99 m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135:550–555 (discussion 555–557)CrossRefPubMedGoogle Scholar
  12. 12.
    Chou F, Lee C, Chen J et al (2002) Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 137:341–344CrossRefPubMedGoogle Scholar
  13. 13.
    Bieglmayer C, Kaczirek K, Prager G et al (2006) Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidism: pilot study of the impact of renal function and assay specificity. Clin Chem 52:1112–1119CrossRefPubMedGoogle Scholar
  14. 14.
    Kaczirek K, Riss P, Wunderer G et al (2005) Quick PTH assay cannot predict incomplete parathyroidectomy in patients with renal hyperparathyroidism. Surgery 137:431–435CrossRefPubMedGoogle Scholar
  15. 15.
    Kaczirek K, Prager G, Riss P et al (2006) Novel parathyroid hormone (1–84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism. Arch Surg 141:129–134 (discussion 134)CrossRefPubMedGoogle Scholar
  16. 16.
    Gioviale M, Gambino G, Maione C et al (2006) Intraoperative parathyroid hormone monitoring during parathyroidectomy for hyperparathyroidism in waiting list and kidney transplant patients. Transplant Proc 38:1003–1005CrossRefPubMedGoogle Scholar
  17. 17.
    Thanasoulis L, Bingener J, Sirinek K et al (2007) A successful application of the intraoperative parathyroid hormone assay in tertiary hyperparathyroidism. Am Surg 73:281–283PubMedGoogle Scholar
  18. 18.
    Triponez F, Dosseh D, Hazzan M et al (2006) Accuracy of intra-operative PTH measurement during subtotal parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. Langenbecks Arch Surg 391:561–565CrossRefPubMedGoogle Scholar
  19. 19.
    Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41CrossRefPubMedGoogle Scholar
  20. 20.
    Levey AS, Coresh J, Greene T et al (2007) Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772CrossRefPubMedGoogle Scholar
  21. 21.
    National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201Google Scholar
  22. 22.
    Triponez F, Kebebew E, Dosseh D et al (2006) Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation. Surgery 140:990–997 (discussion 997–999)CrossRefPubMedGoogle Scholar
  23. 23.
    Nichol P, Starling J, Mack E et al (2002) Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 235:673–678 (discussion 678–680)CrossRefPubMedGoogle Scholar
  24. 24.
    Nichol P, Mack E, Bianco J et al (2003) Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery 134:713–717 (discussion 717–719)CrossRefPubMedGoogle Scholar
  25. 25.
    Alexander HR Jr, Chen CC, Shawker T et al (2002) Role of preoperative localization and intraoperative localization maneuvers including intraoperative PTH assay determination for patients with persistent or recurrent hyperparathyroidism. J Bone Miner Res 17 Suppl 2:N133–N140PubMedGoogle Scholar
  26. 26.
    Irvin G, Molinari A, Figueroa C et al (1999) Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 229:874–878 (discussion 878–879)CrossRefPubMedGoogle Scholar
  27. 27.
    Jorna F, Jager P, Lemstra C et al (2008) Utility of an intraoperative gamma probe in the surgical management of secondary or tertiary hyperparathyroidism. Am J Surg 196:13–18CrossRefPubMedGoogle Scholar
  28. 28.
    Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–670 (discussion 670–662)CrossRefPubMedGoogle Scholar
  29. 29.
    Berber E, Parikh R, Ballem N et al (2008) Factors contributing to negative parathyroid localization: an analysis of 1000 patients. Surgery 144:74–79CrossRefPubMedGoogle Scholar
  30. 30.
    Gilat H, Feinmesser R, Vinkler Y et al (2007) Clinical and operative management of persistent hyperparathyroidism after renal transplantation: a single-center experience. Head Neck 29:996–1001CrossRefPubMedGoogle Scholar
  31. 31.
    Cohen E, Moulder J (2001) Parathyroidectomy in chronic renal failure: has medical care reduced the need for surgery? Nephron 89:271–273CrossRefPubMedGoogle Scholar
  32. 32.
    Kilgo M, Pirsch J, Warner T et al (1998) Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery 124:677–683 (discussion 683–674)CrossRefPubMedGoogle Scholar
  33. 33.
    Gasparri G, Camandona M, Abbona G et al (2001) Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233:65–69CrossRefPubMedGoogle Scholar
  34. 34.
    Punch J, Thompson N, Merion R (1995) Subtotal parathyroidectomy in dialysis-dependent and post-renal transplant patients. A 25-year single-center experience. Arch Surg 130:538–542 (discussion 542–533)PubMedGoogle Scholar
  35. 35.
    Triponez F, Dosseh D, Hazzan M et al (2005) Subtotal parathyroidectomy with thymectomy for autonomous hyperparathyroidism after renal transplantation. Br J Surg 92:1282–1287CrossRefPubMedGoogle Scholar
  36. 36.
    Milas M, Weber C (2004) Near-total parathyroidectomy is beneficial for patients with secondary and tertiary hyperparathyroidism. Surgery 136:1252–1260CrossRefPubMedGoogle Scholar
  37. 37.
    Weber K, Misra S, Lee J et al (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136:1154–1159CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Susan C. Pitt
    • 1
  • Rajarajan Panneerselvan
    • 1
  • Herbert Chen
    • 1
  • Rebecca S. Sippel
    • 1
  1. 1.Department of Surgery, Section of Endocrine SurgeryUniversity of WisconsinMadisonUSA

Personalised recommendations